Physician profile
Arthur C Lee
NPI 1063447977
$1,769,509.95
in general payments reported to CMS, 2019-2025
77 companies · $73K in 2025
The $73K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $319K · 2020: $188K · 2021: $318K · 2022: $340K · 2023: $288K · 2024: $244K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $358K · Consulting Fee: $87K · Honoraria: $49K · Travel and Lodging: $44K · Long Term Medical Supply Or Device Loan: $41K · Food and Beverage: $25K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $357,926.00 |
| Consulting Fee | $87,325.05 |
| Honoraria | $49,375.00 |
| Travel and Lodging | $43,534.99 |
| Long Term Medical Supply Or Device Loan | $41,485.00 |
| Food and Beverage | $24,881.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $547,586.27 | 2019-2024 | Xarelto |
| Amgen INC. | $468,423.11 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205,942.30 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $124,106.17 | 2019-2025 | Jardiance |
| Bard Peripheral Vascular, INC. | $113,270.08 | 2019-2025 | Rotarexs 6 F X 135 Cm, Crosser Iq, Venclose Maven Catheter |
| Angiodynamics, INC. | $55,787.89 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Cook Incorporated | $54,649.68 | 2019-2025 | Zilver Ptx, Advance |
| Lexicon Pharmaceuticals, INC. | $38,934.03 | 2023-2024 | Inpefa |
| Inari Medical, INC. | $25,177.85 | 2022-2025 | Limflow System, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Limflow INC. | $20,328.25 | 2023 | Limflow System |
| Abbott Laboratories | $20,043.91 | 2019-2024 | Perclose Proglide, Supera, Jeti Peripheral Catheter |
| Penumbra, INC. | $15,895.38 | 2019-2024 | Indigo System, Penumbra System |
| Cardiovascular Systems INC. | $14,156.07 | 2019-2022 | |
| Amarin Pharma, INC. | $13,174.93 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $12,535.78 | 2019-2025 | Farxiga |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $9,375.44 | 2021-2022 | |
| Cook Medical LLC | $7,639.16 | 2019-2025 | Zilver Ptx, Cook, Icast Covered Stent System, 6mmx22mmx120cm |
| Cordis US Corp. | $3,679.98 | 2024-2025 | Selution Slrpta, Mynx Control Venous, S.M.A.R.T. Control |
| Wilson Cook Medical Incorporated | $3,225.00 | 2023 | Zilver Vena |
| C. R. Bard, INC. & Subsidiaries | $2,012.50 | 2022 | |
| Merit Medical Systems INC | $1,750.00 | 2020-2022 | |
| Boston Scientific Corporation | $1,491.76 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Resonate El Icd Vr |
| Shockwave Medical, INC | $1,079.76 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $1,064.85 | 2019-2025 | Gore Cardioform Septal Occluder |
| Stryker Corporation | $669.69 | 2025 | Limflow System, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $561.61 | 2019-2025 | |
| Endologix LLC | $550.32 | 2023-2025 | Endocross Device, Torus Stent Graft System |
| Intact Vascular, INC. | $401.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $391.56 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $367.63 | 2022-2025 | Symplicity G3, Azure Xt Dr Mri Surescan, Telescope |
| Pfizer INC. | $355.86 | 2019-2025 | |
| Esperion Therapeutics, INC. | $320.30 | 2020-2021 | |
| Abiomed | $286.42 | 2019-2025 | |
| Medtronic Vascular, INC. | $284.73 | 2019-2020 | |
| Cms Imaging, INC. | $272.13 | 2025 | |
| Cvrx, INC. | $234.31 | 2024-2025 | Barostim Neo System |
| Cardio Flow, INC. | $217.59 | 2024 | |
| Edwards Lifesciences Corporation | $211.93 | 2021 | |
| Acist Medical Systems, INC. | $204.09 | 2019-2020 | |
| Inspiremd Ltd | $203.34 | 2023-2025 | Cguard Prime Carotid Stent System, Cguard |
| Avinger INC. | $193.02 | 2019 | |
| Merck Sharp & Dohme LLC | $190.23 | 2023-2025 | Verquvo |
| Philips North America LLC | $185.28 | 2020-2024 | (Br5) Peripheral Ivus, (Ck6) Holter |
| Innova Vascular INC. | $159.87 | 2024 | |
| Veryan Medical Incorporated | $150.00 | 2020 | |
| Kestra Medical Technology Services, INC. | $149.66 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $147.37 | 2019-2023 | Lifevest |
| Celonova Biosciences, INC. | $136.38 | 2019 | |
| Venclose INC. | $117.67 | 2020 | |
| Novo Nordisk INC | $111.77 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.46 | 2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $97.38 | 2022-2023 | Arcalyst |
| Recor Medical INC | $87.21 | 2024 | Paradise Renal Denervation System |
| Organogenesis INC. | $85.47 | 2019 | |
| Opsens INC. | $85.20 | 2020 | |
| Siemens Medical Solutions USA, INC. | $81.20 | 2019-2021 | |
| Ge Healthcare | $67.42 | 2019-2023 | |
| Reflow Medical INC | $59.75 | 2024-2025 | |
| Inquis Medical, INC. | $56.43 | 2025 | Aventus |
| Silk Road Medical, INC. | $50.29 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Livanova USA, INC. | $48.29 | 2022 | |
| Sanofi-Aventis U.S. LLC | $38.30 | 2019 | |
| Avantec Vascular Corporation | $36.49 | 2021 | |
| Astellas Pharma US INC | $33.80 | 2019-2020 | |
| Cashflow Solutions, LLC | $31.44 | 2022-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Imperative Care, INC | $24.99 | 2024 | Prodigy Catheter |
| Smith+Nephew, INC. | $24.50 | 2019 | |
| Zoll Circulation INC | $19.78 | 2020 | |
| Idorsia Pharmaceuticals US INC | $19.52 | 2025 | Tryvio |
| Atricure, INC. | $18.00 | 2020 | |
| Terumo Medical Corporation | $17.52 | 2020 | |
| Neuros Medical, INC. | $13.93 | 2025 | Altius |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$16,915.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$1,008,744.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.